Nachrichten zur CRISPR Therapeutics AG Aktie

CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $49.13, moving +0.99% from the previous trading session....…

Insiderhandel: Chief Executive Officer verkauft Aktien von Crispr Therapeutics im Wert von 1.266.637$

Kulkarni, Samarth - Vorstand - Tag der Transaktion: 2023-04-25...…

Why CRISPR Therapeutics Just Became an Even Better Buy

Is this a no-brainer investment to add to your portfolio?...…

Why CRISPR Therapeutics Stock Is Marching Higher Today

This gene-editing stock has been heating up over the past week....…

Better Growth Stock: Axsome vs. CRISPR Therapeutics

These companies are both in the early days of their growth stories....…

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $50.31 in the latest trading session, marking a -0.49% move from the prior day....…

Is BioRad Laboratories (BIO) Stock Outpacing Its Medical Peers This Year?

Here is how Bio-Rad Laboratories (BIO) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this…

Is CRISPR Therapeutics Stock a Buy Now?

The biotech could soon be a commercial-stage company....…

CRISPR Therapeutics AG (CRSP) Soars 16.3%: Is Further Upside Left in the Stock?

CRISPR Therapeutics AG (CRSP) saw its shares surge in the last session with trading volume being higher than average. The…

Why Shares of CRISPR Therapeutics Jumped Thursday

An independent drug-pricing group said that a $1.9 million cost for the companys exa-cel therapy would be cost-effective....…

Wall Street Analysts Think CRISPR Therapeutics AG (CRSP) Could Surge 105.26%: Read This Before Placing a Bet

The mean of analysts price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While…

Where Will CRISPR Therapeutics Be in 5 Years?

Could CRISPR Therapeutics be the next big healthcare stock?...…

CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $45.28, moving +0.11% from the previous trading session....…

Form 8-K CRISPR Therapeutics AG For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

CRISPR Therapeutics sichert sich Lizenzgeschäft im Wert von bis zu 330 Mio. USD

Das 2013 gegründete Unternehmen wurde zwischen 2015 und 2019 jedes Jahr zu einem der TOP 100 Schweizer Startups gewählt....…

Form 8-K CRISPR Therapeutics AG For: Mar 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K CRISPR Therapeutics AG For: Mar 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Could CRISPR Therapeutics Become the Next Moderna?

Both companies use cutting-edge technology....…

CRISPR Therapeutics AG (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?

CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals

CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals are part of the Zacks Industry Outlook article....…

CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $45.06, marking a +1.35% move from the previous day....…

CRISPR Therapeutics AG (CRSP) Stock Moves -0.51%: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $44.92, moving -0.51% from the previous trading session....…

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $45.15 in the latest trading session, marking a -1.25% move from the prior day....…

CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting

ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on…

Form 8-K CRISPR Therapeutics AG For: Mar 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Raju Prasad named next CFO of CRISPR Therapeutics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

CRISPR Therapeutics Announces Transition of Chief Financial Officer

ZUG, Switzerland and BOSTON, March 13, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused…

Growth stocks in focus: can buying CRISPR Therapeutics at $50 make me rich?

Dr James Fox takes a closer look at one of the most promising growth stocks, CRISPR Therapeutics. Could this gene-editing…

If You Invested $10,000 in CRISPR Therapeutics In 2020, This Is How Much You Would Have Today

The stock has been on a wild ride over the past few years....…

Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold

Get in on CRISPR Therapeutics before it gets expensive....…

Better Growth Stock: Moderna vs. CRISPR Therapeutics

Both stocks are ripe for a rebound....…

3 Things About CRISPR Therapeutics That Smart Investors Know

Institutional investors might be on to something....…

Insiderhandel: Chief Executive Officer verkauft Aktien von Crispr Therapeutics im Wert von 1.206.243$

Kulkarni, Samarth - Vorstand - Tag der Transaktion: 2023-02-27...…

What Makes CRISPR Therapeutics AG (CRSP) a New Buy Stock

CRISPR Therapeutics AG (CRSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings…

Crispr Therapeutics Stock Gains on Hope for Sickle-Cell Gene Therapy

The company said it expects to complete a filing for FDA approval for the treatment by March, highlighting its lead…

Zuger Crispr Therapeutics mit hohem Verlust im Jahr 2022

Im letzten Geschäftsjahr schrieb das Biotechunternehmen ein Minus von 650 Millionen Dollar. Das schwache Ergebnis hatte sich abgezeichnet....…

Crispr Therapeutics mit hohem Verlust im Jahr 2022

Biotechnologie - Das an der Nasdaq kotierte Biotechunternehmen Crispr Therapeutics mit Sitz in Zug hat das Geschäftsjahr 2022 in den roten…

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Misses Revenue Estimates

CRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of 39.22% and 99.95%, respectively, for the quarter ended December 2022.…

CRISPR Therapeutics GAAP EPS of -$1.41 beats by $0.90

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

-Regulatory submissions complete for exagamglogene autotemcel (exa-cel) in Europe for transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD); U.S.…

Form 8-K CRISPR Therapeutics AG For: Feb 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Beat the Dow Jones With CRISPR Therapeutics Stock

If approved, CRISPRs first product may deliver blockbuster sales....…

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $50.87 in the latest trading session, marking a -1.24% move from the prior day....…

Could CRISPR Therapeutics Stock Help You Become a Millionaire?

The gene-editing business has loads of potential, but is it enough to make you rich?...…

Better Bull Market Buy: CRISPR Therapeutics or Vertex Pharmaceuticals?

Both stocks should be winners if gene-editing therapy exa-cel wins regulatory approvals....…

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company…

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $55.27 in the latest trading session, marking a -1.51% move from the prior day....…

Strength Seen in CRISPR Therapeutics AG (CRSP): Can Its 7.2% Jump Turn into More Strength?

CRISPR Therapeutics AG (CRSP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate…

Insiderhandel: Chief Executive Officer verkauft Aktien von Crispr Therapeutics im Wert von 1.286.798$

Kulkarni, Samarth - Vorstand - Tag der Transaktion: 2023-01-27...…

3 Things About CRISPR Therapeutics That Smart Investors Know

The gene-therapy specialists near-term outlook is quite bullish....…